See the DrugPatentWatch profile for Nplate
What is Nplate, and what is it used for?
Nplate is the brand name of romiplostim, a medicine used to treat certain people with low platelet counts (thrombocytopenia) caused by specific conditions, including immune thrombocytopenia (ITP) in adults who have had an insufficient response to other treatments.[1]
How does Nplate work?
Nplate is a thrombopoietin receptor agonist. It helps stimulate platelet production by activating the thrombopoietin receptor on cells involved in making platelets.[1]
How is Nplate given?
Nplate is given as an injection.[1]
Who should not take Nplate, and what precautions apply?
People with very low or unstable platelet counts, those with bleeding, and those who have other blood-related conditions may need careful monitoring. Dosing and monitoring are important because the goal is to raise platelets without pushing them too high.[1]
What side effects are associated with Nplate?
Commonly reported issues with thrombopoietin receptor agonists include headache, dizziness, and joint or muscle pain, and injection-site reactions. Serious risks can include excessively high platelet counts and related clotting complications, which is why platelet monitoring is central to treatment.[1]
What monitoring is needed while on Nplate?
Patients typically need regular platelet count checks and dose adjustments based on those results to keep platelet levels within the target range and reduce risks associated with high platelets.[1]
Is Nplate approved for children, and how does dosing differ?
Nplate use depends on the specific regulatory indications in a given country. Dosing is adjusted by platelet response rather than fixed by age alone, so pediatric regimens generally still require weight-based and response-based adjustments.[1]
What are alternatives to Nplate for thrombocytopenia/ITP?
For ITP, alternatives can include corticosteroids, other ITP medicines (including other thrombopoietin receptor agonists), and other therapies depending on patient factors and prior response. Which option fits best depends on how chronic the condition is and how patients respond to initial treatments.[1]
Sources
- https://www.medicines.org.uk/emc/product/122/smpc